In a new kind of real-world study, a “pragmatic” clinical trial, UF researchers found that hepatitis C patients who previously did not respond to oral drug therapy were cured by a recently approved drug regimen. The study, published in the journal Gastroenterology’s December issue (available online) showed that the fixed-dose combination of glecaprevir/pibrentasvir, marketed as … Continue reading Study Helps Hepatitis C Patients, Shows Path for Accelerating Research and Potential for Drug Approvals